KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) EBITDA (2016 - 2025)

Sabra Health Care REIT (SBRA) has 10 years of EBITDA data on record, last reported at $55.0 million in Q4 2025.

  • For Q4 2025, EBITDA fell 26.92% year-over-year to $55.0 million; the TTM value through Dec 2025 reached $265.9 million, up 9.26%, while the annual FY2025 figure was $265.9 million, 9.26% up from the prior year.
  • EBITDA reached $55.0 million in Q4 2025 per SBRA's latest filing, up from $50.6 million in the prior quarter.
  • Across five years, EBITDA topped out at $92.7 million in Q2 2025 and bottomed at $14.2 million in Q3 2023.
  • Average EBITDA over 5 years is $51.9 million, with a median of $54.3 million recorded in 2024.
  • Peak YoY movement for EBITDA: tumbled 76.63% in 2021, then skyrocketed 315.23% in 2024.
  • A 5-year view of EBITDA shows it stood at $15.1 million in 2021, then skyrocketed by 198.89% to $45.1 million in 2022, then increased by 3.02% to $46.5 million in 2023, then surged by 61.97% to $75.2 million in 2024, then decreased by 26.92% to $55.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $55.0 million in Q4 2025, $50.6 million in Q3 2025, and $92.7 million in Q2 2025.